
Erik S. Lesser/Getty Images News
Pharmaceutical company Merck (NYSE:MRK) is set to report its second quarter earnings on Tuesday, July 29th, before the opening bell.
Analysts expect a 11% decline in earnings per share to $2.03 on a revenue of $15.87B, a 1.4% decrease from last year.